Trial Details

COMPLETED
Basic Information
Clinical ID c4647
Identifier NCT00207662
Trial Title A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: infliximab or placebo
Participant Information
Sponsor Centocor, Inc.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2000-07
Primary Completion Date -
Completion Date 2005-11